Ascó, Spain Mainstream News, Events and Opinion on Allvoices
Front Page

Ascó News

 
 
   
Source: BusinessInsider

Ascó :: Spain | updated 2014-06-04 09:31:11 -0700 | health-news

Research presented at a US conference has revived hopes of eventually curing cancer, but at what cost?...As thousands of researchers, clinicians and policy-holders met in Chicago on May 30th to June 3rd, the presentations have sparked headlines about breakthroughs resulting...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Guardian Unlimited

Ascó :: Spain | updated 2014-06-02 11:35:36 -0700 | health-news

AstraZeneca's chief executive, Pascal Soriot is under pressure from investors to deliver top-selling treatments after fighting Pfizer's bid. Photograph: Reuters AstraZeneca will this weekend give an update on the three cancer drugs that were at the centre of its succesful...
Credibility  
Views: 5   News Stories: 1
Blog Posts: 0 1 0 0
 
 
   
Source: The Motley Fool

Ascó :: Spain | updated 2014-06-07 10:32:37 -0700 | health-news

S&P Biotech Index up 25% over the trailing 12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and companies that...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Daily Southtown

Ascó :: Spain | updated 2014-07-11 23:48:10 -0700 | health-news

Ingalls Cancer Care medical director Dr. Mark Kozloff, Ingalls Cancer Research director Margaret Marriott, Amber Kindt, Lynn Muir and Alan Fisher. Updated: July 11, 2014 9:58PM Ingalls Memorial Hospital in Harvey is one of two hospitals in Illinois, and the...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: The Motley Fool

Ascó :: Spain | updated 2014-06-05 06:35:43 -0700 | health-news

Cancer Drug Showdown While immuno-oncology was certainly hot at this year's American Society of Clinical Oncology meeting, there were plenty of data on other interesting cancer drugs presented at the cancer confab. Iclusig in gastrointestinal stromal tumors, showing that about...
Credibility  
Views: 3   News Stories: 3
Blog Posts: 0 0 0 0
 
   
Source: The Motley Fool

Ascó :: Spain | updated 2014-06-02 16:39:12 -0700 | business-news

In a phase 1/2 trial, CO-1686 caused high blood sugar in 22% of patients, according to Clovis, and CEO Pat Mahaffay reportedly commented that a few patients had to receive insulin injections to handle their hyperglycemia. In this video, from...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
   
Source: Newswise

Ascó :: Spain | updated 2014-06-01 08:40:28 -0700 | health-news

But in order to make this match, oncologists have to know these genetics...Annual Meeting 2014 details the challenges in this process and makes recommendations that oncologists can use to ensure their patients' samples are properly tested, helping to pair patients...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Taiwan News

Ascó :: Spain | updated 2014-06-01 07:26:53 -0700 | health-news

R (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine in treatment-naive patients with metastatic pancreatic cancer...The extended data cutoff occurred at final database lock in May 2013 and allowed for an OS analysis of mature data...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: The Motley Fool

Ascó :: Spain | updated 2014-06-11 14:26:12 -0700 | health-news

Competition Heats Up Gains in cancer research are maddeningly hard to understand, and many new drug regimens are extremely toxic...The report was one factor that sent the stock plunging 6% last Thursday morning...BMO analysts downgraded the stock amid concerns about...
Credibility  
Views: 4   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Money Morning

Ascó :: Spain | updated 2014-06-12 05:00:13 -0700 | health-news

The American Society of Clinical Oncology meets every spring. It's attended by some 30,000 people and hosts 4,000 presentations...It's so big, in fact, that stock-watchers are talking about the trend as "Immunopalooza." "Rarely a week goes by without a few...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Newswise

Ascó :: Spain | updated 2014-06-02 10:09:35 -0700 | health-news

Video and audio are available for download on the Mayo Clinic News Network . Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization study), demonstrated that adding lapatinib to trastuzumab and chemotherapy did not improve patient outcome (defined as disease-free survival or overall...
Credibility  
Views: 1   News Stories: 2
Blog Posts: 0 0 0 0
 
 
   
Source: Newswise

Ascó :: Spain | updated 2014-06-10 05:55:20 -0700 | health-news

BluePrint® tests to data from the first-generation, 21-gene test...Dabbs, M.D., Adam Brufsky, M.D. and colleagues at the University of Pittsburgh and related institutions presented the findings, which encompassed five-year outcome data from 437 patients.
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Newswise

Ascó :: Spain | updated 2014-06-02 10:18:08 -0700 | health-news

Presentations include discovery of a new gene alteration that can aid in detection and treatment of certain lung cancers, insights into lung cancer patient populations impacted by HIV and evaluation of breast cancer treatments...TOR protein complex that regulates cell proliferation...
Credibility  
Views: 0   News Stories: 1
Blog Posts: 0 0 0 0
 
   
Source: Money Morning

Ascó :: Spain | updated 2014-06-16 12:30:47 -0700 | health-news

Our fifth biotech pick has already tripled in value in the last six months, and it's not done yet. Another catalyst is about to send its shares soaring in mid-July, and you'll want to get in before the boom. Aside...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
   
Source: Newswise

Ascó :: Spain | updated 2014-06-02 11:26:52 -0700 | health-news

May 30-June 3, 2014 in Chicago, including data on new treatment approaches for thyroid, head and neck, and recurrent ovarian cancers; and new biomarkers for bile duct cancers. MAY 31, 8:00 11:45 AM) In a study led by Amy Tiersten,...
Credibility  
Views: 0   News Stories: 4
Blog Posts: 0 0 0 0
 

Build Your Allvoices Brand. Gain Influence. Make Money.

Join the Build Your Allvoices Brand Incentive Program



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.